Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model

Circulation

Volumn 104, Issue 10, 2001, Pages 1188-1193

  Suzuki, Takeshi ^a   Kopia, Greg ^b   Hayashi, Shin Ichiro ^a   Bailey, Lynn R ^a   Llanos, Gerard ^b   Wilensky, Robert ^c   Klugherz, Bruce D ^c   Papandreou, George ^b   Narayan, Pallassana ^b   Leon, Martin B ^d   Yeung, Alan C ^a   Tio, Fermin ^e   Tsao, Philip S ^a   Falotico, Robert ^b   Carter, Andrew J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Medical Affairs and Health Ecomomics Worldwide   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d LENOX HILL HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Restenosis; Sirolimus; Stents

Indexed keywords

CYCLINE; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; POLYMER; RAPAMYCIN; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ANIMAL TISSUE; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DOG; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TISSUE LEVEL; GENE EXPRESSION; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0035806921     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3601.093987     Document Type: Article

References (18)

1. Percutaneous coronary interventions in the current era compared with 1985-1986: The National Heart, Lung, and Blood Institute Registries
2. Patterns of in-stent restenosis: Angiographic classification and implications for long-term clinical outcome
3. Pathology of acute and chronic coronary stenting in humans
4. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen
5. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia
6. Cell cycle progression: New therapeutic target for vascular proliferative disease
7. Frontiers in interventional cardiology
8. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury
9. Rapamycin inhibits VSMC migration
10. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in VSMC
11. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle
12. Newer immunosuppressive drugs: A review
13. Morphologic characteristics of lesion formation and the time course of smooth muscle cell proliferation in a porcine proliferative restenosis model
14. Biocompatibility aspects of new stent technology
15. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries
16. Differential neointimal response to coronary artery injury in pigs and dogs: Implications for restenosis models
17. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
18. 32P radioactive β-emitting stents